CrystalGenomics Completes Stock Listing with Name Change to CG InVites

"InVites Ecosystem Integration"

CG Inbites announced on the 3rd that the stock ticker symbol has been changed from Crystal Genomics to CG Inbites, completing its listing.

The company stated that at the extraordinary general meeting of shareholders held in June, the name change to CG Inbites was approved following a change in the largest shareholder. The new name, CG Inbites, signifies that the former Crystal Genomics has been incorporated into the Inbites ecosystem, according to the company.

The Inbites ecosystem is described by CG Inbites as a model that builds a full-cycle value chain in the data-driven bio healthcare sector. It consists of 11 specialized bio healthcare companies, including Inbites BioCore, CG Inbites, HealthConnect, Inbites Healthcare, Inbites Genomics, Prokagen, Crystal Bioscience, and Crystal Life Science.

A CG Inbites representative said, "With the change of the largest shareholder, we changed the company name to pledge a new leap forward together with the newly appointed board of directors. We aim to gain more growth and investment opportunities in this rapidly changing environment and thereby create new value for the company."

CG Inbites CI. [Image provided by CG Inbites]

This content was produced with the assistance of AI translation services.